In the eyes of the United States, Canada has a drug problem.
Granted, this isn't an illegal narcotics or drug cartel problem. But in the world of international trade, the problem is pretty bad. In fact, it's serious enough to land Canada on the "Watch List" in the U.S. Trade Representative's "Special 301 Report"—a report released annually that evaluates the intellectual property rights protection and enforcement of the United States's trading partners.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
